nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclopentolate—BCHE—Ramipril—type 2 diabetes mellitus	0.51	1	CbGbCtD
Cyclopentolate—Abdominal distension—Miglitol—type 2 diabetes mellitus	0.0062	0.0225	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Glimepiride—type 2 diabetes mellitus	0.00566	0.0205	CcSEcCtD
Cyclopentolate—Vasodilation—Glimepiride—type 2 diabetes mellitus	0.00566	0.0205	CcSEcCtD
Cyclopentolate—Abdominal distension—Tolbutamide—type 2 diabetes mellitus	0.00558	0.0202	CcSEcCtD
Cyclopentolate—Abdominal distension—Tolazamide—type 2 diabetes mellitus	0.00507	0.0184	CcSEcCtD
Cyclopentolate—Coma—Glimepiride—type 2 diabetes mellitus	0.00454	0.0165	CcSEcCtD
Cyclopentolate—Gastroenteritis—Pioglitazone—type 2 diabetes mellitus	0.00418	0.0152	CcSEcCtD
Cyclopentolate—Gastroenteritis—Sitagliptin—type 2 diabetes mellitus	0.00406	0.0147	CcSEcCtD
Cyclopentolate—Coma—Gliclazide—type 2 diabetes mellitus	0.00337	0.0122	CcSEcCtD
Cyclopentolate—Psychotic disorder—Bromocriptine—type 2 diabetes mellitus	0.00318	0.0115	CcSEcCtD
Cyclopentolate—Vertigo—Tolazamide—type 2 diabetes mellitus	0.00315	0.0114	CcSEcCtD
Cyclopentolate—Abdominal distension—Glimepiride—type 2 diabetes mellitus	0.00314	0.0114	CcSEcCtD
Cyclopentolate—Urinary retention—Bromocriptine—type 2 diabetes mellitus	0.0031	0.0112	CcSEcCtD
Cyclopentolate—Ataxia—Bromocriptine—type 2 diabetes mellitus	0.00306	0.0111	CcSEcCtD
Cyclopentolate—Tremor—Nateglinide—type 2 diabetes mellitus	0.00305	0.0111	CcSEcCtD
Cyclopentolate—Gastroenteritis—Gliclazide—type 2 diabetes mellitus	0.00302	0.0109	CcSEcCtD
Cyclopentolate—Drowsiness—Glipizide—type 2 diabetes mellitus	0.00298	0.0108	CcSEcCtD
Cyclopentolate—Coordination abnormal—Irbesartan—type 2 diabetes mellitus	0.00296	0.0107	CcSEcCtD
Cyclopentolate—Conjunctivitis—Glipizide—type 2 diabetes mellitus	0.0029	0.0105	CcSEcCtD
Cyclopentolate—Drowsiness—Glimepiride—type 2 diabetes mellitus	0.00278	0.0101	CcSEcCtD
Cyclopentolate—Abdominal distension—Glyburide—type 2 diabetes mellitus	0.00259	0.00939	CcSEcCtD
Cyclopentolate—Drowsiness—Bromocriptine—type 2 diabetes mellitus	0.00251	0.0091	CcSEcCtD
Cyclopentolate—Flushing—Glipizide—type 2 diabetes mellitus	0.00248	0.009	CcSEcCtD
Cyclopentolate—Gastroenteritis—Irbesartan—type 2 diabetes mellitus	0.00238	0.00863	CcSEcCtD
Cyclopentolate—Abdominal distension—Gliclazide—type 2 diabetes mellitus	0.00233	0.00843	CcSEcCtD
Cyclopentolate—Hallucination—Bromocriptine—type 2 diabetes mellitus	0.00224	0.00813	CcSEcCtD
Cyclopentolate—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.00223	0.00808	CcSEcCtD
Cyclopentolate—Rash—Miglitol—type 2 diabetes mellitus	0.00221	0.00801	CcSEcCtD
Cyclopentolate—Dermatitis—Miglitol—type 2 diabetes mellitus	0.00221	0.008	CcSEcCtD
Cyclopentolate—Vision blurred—Glipizide—type 2 diabetes mellitus	0.0022	0.00796	CcSEcCtD
Cyclopentolate—Tremor—Glipizide—type 2 diabetes mellitus	0.00218	0.00791	CcSEcCtD
Cyclopentolate—Desvenlafaxine—CYP3A4—type 2 diabetes mellitus	0.00214	0.32	CrCbGaD
Cyclopentolate—Abdominal distension—Orlistat—type 2 diabetes mellitus	0.00211	0.00766	CcSEcCtD
Cyclopentolate—Vertigo—Glipizide—type 2 diabetes mellitus	0.00209	0.00759	CcSEcCtD
Cyclopentolate—Drowsiness—Gliclazide—type 2 diabetes mellitus	0.00206	0.00747	CcSEcCtD
Cyclopentolate—Vision blurred—Glimepiride—type 2 diabetes mellitus	0.00205	0.00743	CcSEcCtD
Cyclopentolate—Vision blurred—Sitagliptin—type 2 diabetes mellitus	0.00204	0.0074	CcSEcCtD
Cyclopentolate—Tremor—Glimepiride—type 2 diabetes mellitus	0.00204	0.00738	CcSEcCtD
Cyclopentolate—Pruritus—Tolazamide—type 2 diabetes mellitus	0.00203	0.00735	CcSEcCtD
Cyclopentolate—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.00203	0.00735	CcSEcCtD
Cyclopentolate—Vertigo—Pioglitazone—type 2 diabetes mellitus	0.00201	0.00727	CcSEcCtD
Cyclopentolate—Conjunctivitis—Gliclazide—type 2 diabetes mellitus	0.002	0.00726	CcSEcCtD
Cyclopentolate—Agitation—Glimepiride—type 2 diabetes mellitus	0.002	0.00724	CcSEcCtD
Cyclopentolate—Rash—Tolbutamide—type 2 diabetes mellitus	0.00199	0.0072	CcSEcCtD
Cyclopentolate—Vertigo—Sitagliptin—type 2 diabetes mellitus	0.00195	0.00706	CcSEcCtD
Cyclopentolate—Abdominal distension—Metformin—type 2 diabetes mellitus	0.00195	0.00706	CcSEcCtD
Cyclopentolate—Gastroenteritis—Ramipril—type 2 diabetes mellitus	0.00192	0.00697	CcSEcCtD
Cyclopentolate—Convulsion—Glimepiride—type 2 diabetes mellitus	0.00188	0.00683	CcSEcCtD
Cyclopentolate—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00188	0.00681	CcSEcCtD
Cyclopentolate—Ataxia—Losartan—type 2 diabetes mellitus	0.00187	0.00677	CcSEcCtD
Cyclopentolate—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.00185	0.0067	CcSEcCtD
Cyclopentolate—Abdominal distension—Irbesartan—type 2 diabetes mellitus	0.00184	0.00666	CcSEcCtD
Cyclopentolate—Dry mouth—Glimepiride—type 2 diabetes mellitus	0.00181	0.00656	CcSEcCtD
Cyclopentolate—Rash—Tolazamide—type 2 diabetes mellitus	0.00181	0.00655	CcSEcCtD
Cyclopentolate—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00181	0.00655	CcSEcCtD
Cyclopentolate—Dry mouth—Sitagliptin—type 2 diabetes mellitus	0.0018	0.00654	CcSEcCtD
Cyclopentolate—Agitation—Bromocriptine—type 2 diabetes mellitus	0.0018	0.00653	CcSEcCtD
Cyclopentolate—Rash—Linagliptin—type 2 diabetes mellitus	0.00179	0.00648	CcSEcCtD
Cyclopentolate—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00179	0.00648	CcSEcCtD
Cyclopentolate—Vertigo—Bromocriptine—type 2 diabetes mellitus	0.00176	0.00639	CcSEcCtD
Cyclopentolate—Rash—Acarbose—type 2 diabetes mellitus	0.00174	0.00629	CcSEcCtD
Cyclopentolate—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00173	0.00629	CcSEcCtD
Cyclopentolate—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.00173	0.00628	CcSEcCtD
Cyclopentolate—Drowsiness—Metformin—type 2 diabetes mellitus	0.00172	0.00625	CcSEcCtD
Cyclopentolate—Flushing—Gliclazide—type 2 diabetes mellitus	0.00172	0.00622	CcSEcCtD
Cyclopentolate—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.0017	0.00616	CcSEcCtD
Cyclopentolate—Somnolence—Glipizide—type 2 diabetes mellitus	0.00169	0.00613	CcSEcCtD
Cyclopentolate—Vision blurred—Glyburide—type 2 diabetes mellitus	0.00169	0.00613	CcSEcCtD
Cyclopentolate—Tremor—Glyburide—type 2 diabetes mellitus	0.00168	0.00609	CcSEcCtD
Cyclopentolate—Rash—Nateglinide—type 2 diabetes mellitus	0.00167	0.00607	CcSEcCtD
Cyclopentolate—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00167	0.00606	CcSEcCtD
Cyclopentolate—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.00163	0.00592	CcSEcCtD
Cyclopentolate—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00163	0.00589	CcSEcCtD
Cyclopentolate—Conjunctivitis—Irbesartan—type 2 diabetes mellitus	0.00158	0.00573	CcSEcCtD
Cyclopentolate—Somnolence—Glimepiride—type 2 diabetes mellitus	0.00158	0.00572	CcSEcCtD
Cyclopentolate—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.00157	0.0057	CcSEcCtD
Cyclopentolate—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00156	0.00566	CcSEcCtD
Cyclopentolate—Convulsion—Glyburide—type 2 diabetes mellitus	0.00155	0.00563	CcSEcCtD
Cyclopentolate—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00154	0.00557	CcSEcCtD
Cyclopentolate—Tremor—Gliclazide—type 2 diabetes mellitus	0.00151	0.00547	CcSEcCtD
Cyclopentolate—Conjunctivitis—Losartan—type 2 diabetes mellitus	0.00149	0.00539	CcSEcCtD
Cyclopentolate—Agitation—Gliclazide—type 2 diabetes mellitus	0.00148	0.00536	CcSEcCtD
Cyclopentolate—Rash—Repaglinide—type 2 diabetes mellitus	0.00145	0.00525	CcSEcCtD
Cyclopentolate—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00145	0.00525	CcSEcCtD
Cyclopentolate—Flushing—Metformin—type 2 diabetes mellitus	0.00144	0.00521	CcSEcCtD
Cyclopentolate—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.00142	0.00516	CcSEcCtD
Cyclopentolate—Convulsion—Gliclazide—type 2 diabetes mellitus	0.00139	0.00506	CcSEcCtD
Cyclopentolate—Vision blurred—Valsartan—type 2 diabetes mellitus	0.00139	0.00505	CcSEcCtD
Cyclopentolate—Vision blurred—Orlistat—type 2 diabetes mellitus	0.00138	0.00499	CcSEcCtD
Cyclopentolate—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00137	0.00496	CcSEcCtD
Cyclopentolate—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00137	0.00496	CcSEcCtD
Cyclopentolate—Flushing—Irbesartan—type 2 diabetes mellitus	0.00136	0.00491	CcSEcCtD
Cyclopentolate—Pruritus—Glipizide—type 2 diabetes mellitus	0.00135	0.00488	CcSEcCtD
Cyclopentolate—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.00134	0.00486	CcSEcCtD
Cyclopentolate—Vertigo—Valsartan—type 2 diabetes mellitus	0.00133	0.00482	CcSEcCtD
Cyclopentolate—Vertigo—Orlistat—type 2 diabetes mellitus	0.00131	0.00476	CcSEcCtD
Cyclopentolate—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00128	0.00465	CcSEcCtD
Cyclopentolate—Conjunctivitis—Ramipril—type 2 diabetes mellitus	0.00128	0.00463	CcSEcCtD
Cyclopentolate—Flushing—Losartan—type 2 diabetes mellitus	0.00128	0.00462	CcSEcCtD
Cyclopentolate—Vision blurred—Metformin—type 2 diabetes mellitus	0.00127	0.0046	CcSEcCtD
Cyclopentolate—Convulsion—Orlistat—type 2 diabetes mellitus	0.00127	0.00459	CcSEcCtD
Cyclopentolate—Tremor—Metformin—type 2 diabetes mellitus	0.00126	0.00458	CcSEcCtD
Cyclopentolate—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00126	0.00455	CcSEcCtD
Cyclopentolate—Dry mouth—Valsartan—type 2 diabetes mellitus	0.00123	0.00447	CcSEcCtD
Cyclopentolate—Dry mouth—Orlistat—type 2 diabetes mellitus	0.00122	0.00441	CcSEcCtD
Cyclopentolate—Rash—Glipizide—type 2 diabetes mellitus	0.0012	0.00435	CcSEcCtD
Cyclopentolate—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.0012	0.00434	CcSEcCtD
Cyclopentolate—Dermatitis—Glipizide—type 2 diabetes mellitus	0.0012	0.00434	CcSEcCtD
Cyclopentolate—Tremor—Irbesartan—type 2 diabetes mellitus	0.00119	0.00432	CcSEcCtD
Cyclopentolate—Agitation—Irbesartan—type 2 diabetes mellitus	0.00117	0.00424	CcSEcCtD
Cyclopentolate—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00117	0.00423	CcSEcCtD
Cyclopentolate—Atropine—CYP1A2—type 2 diabetes mellitus	0.00116	0.173	CrCbGaD
Cyclopentolate—Vertigo—Irbesartan—type 2 diabetes mellitus	0.00114	0.00414	CcSEcCtD
Cyclopentolate—Vision blurred—Losartan—type 2 diabetes mellitus	0.00113	0.00409	CcSEcCtD
Cyclopentolate—Tremor—Losartan—type 2 diabetes mellitus	0.00112	0.00406	CcSEcCtD
Cyclopentolate—Rash—Glimepiride—type 2 diabetes mellitus	0.00112	0.00406	CcSEcCtD
Cyclopentolate—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00112	0.00405	CcSEcCtD
Cyclopentolate—Rash—Sitagliptin—type 2 diabetes mellitus	0.00112	0.00404	CcSEcCtD
Cyclopentolate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00111	0.00404	CcSEcCtD
Cyclopentolate—Agitation—Losartan—type 2 diabetes mellitus	0.0011	0.00399	CcSEcCtD
Cyclopentolate—Flushing—Ramipril—type 2 diabetes mellitus	0.00109	0.00396	CcSEcCtD
Cyclopentolate—Venlafaxine—CYP3A4—type 2 diabetes mellitus	0.00108	0.162	CrCbGaD
Cyclopentolate—Vertigo—Losartan—type 2 diabetes mellitus	0.00107	0.0039	CcSEcCtD
Cyclopentolate—Somnolence—Valsartan—type 2 diabetes mellitus	0.00107	0.00389	CcSEcCtD
Cyclopentolate—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.00106	0.00384	CcSEcCtD
Cyclopentolate—Pruritus—Glyburide—type 2 diabetes mellitus	0.00104	0.00375	CcSEcCtD
Cyclopentolate—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00101	0.00367	CcSEcCtD
Cyclopentolate—Rash—Bromocriptine—type 2 diabetes mellitus	0.00101	0.00366	CcSEcCtD
Cyclopentolate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00101	0.00366	CcSEcCtD
Cyclopentolate—Dry mouth—Losartan—type 2 diabetes mellitus	0.000996	0.00361	CcSEcCtD
Cyclopentolate—Somnolence—Metformin—type 2 diabetes mellitus	0.000977	0.00354	CcSEcCtD
Cyclopentolate—Tremor—Ramipril—type 2 diabetes mellitus	0.000961	0.00348	CcSEcCtD
Cyclopentolate—Tachycardia—Losartan—type 2 diabetes mellitus	0.000953	0.00345	CcSEcCtD
Cyclopentolate—Agitation—Ramipril—type 2 diabetes mellitus	0.000943	0.00342	CcSEcCtD
Cyclopentolate—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00093	0.00337	CcSEcCtD
Cyclopentolate—Rash—Glyburide—type 2 diabetes mellitus	0.000923	0.00334	CcSEcCtD
Cyclopentolate—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000922	0.00334	CcSEcCtD
Cyclopentolate—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000922	0.00334	CcSEcCtD
Cyclopentolate—Vertigo—Ramipril—type 2 diabetes mellitus	0.000922	0.00334	CcSEcCtD
Cyclopentolate—Convulsion—Ramipril—type 2 diabetes mellitus	0.000889	0.00322	CcSEcCtD
Cyclopentolate—Somnolence—Losartan—type 2 diabetes mellitus	0.000868	0.00315	CcSEcCtD
Cyclopentolate—Pruritus—Valsartan—type 2 diabetes mellitus	0.000854	0.0031	CcSEcCtD
Cyclopentolate—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000854	0.0031	CcSEcCtD
Cyclopentolate—Pruritus—Orlistat—type 2 diabetes mellitus	0.000844	0.00306	CcSEcCtD
Cyclopentolate—Rash—Gliclazide—type 2 diabetes mellitus	0.000828	0.003	CcSEcCtD
Cyclopentolate—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000828	0.003	CcSEcCtD
Cyclopentolate—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000817	0.00296	CcSEcCtD
Cyclopentolate—Pruritus—Metformin—type 2 diabetes mellitus	0.000778	0.00282	CcSEcCtD
Cyclopentolate—Rash—Valsartan—type 2 diabetes mellitus	0.000761	0.00276	CcSEcCtD
Cyclopentolate—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00076	0.00276	CcSEcCtD
Cyclopentolate—Rash—Orlistat—type 2 diabetes mellitus	0.000752	0.00273	CcSEcCtD
Cyclopentolate—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000751	0.00272	CcSEcCtD
Cyclopentolate—Somnolence—Ramipril—type 2 diabetes mellitus	0.000744	0.0027	CcSEcCtD
Cyclopentolate—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000734	0.00266	CcSEcCtD
Cyclopentolate—Rash—Metformin—type 2 diabetes mellitus	0.000693	0.00251	CcSEcCtD
Cyclopentolate—Dermatitis—Metformin—type 2 diabetes mellitus	0.000692	0.00251	CcSEcCtD
Cyclopentolate—Pruritus—Losartan—type 2 diabetes mellitus	0.000691	0.0025	CcSEcCtD
Cyclopentolate—Rash—Irbesartan—type 2 diabetes mellitus	0.000654	0.00237	CcSEcCtD
Cyclopentolate—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000654	0.00237	CcSEcCtD
Cyclopentolate—Rash—Losartan—type 2 diabetes mellitus	0.000616	0.00223	CcSEcCtD
Cyclopentolate—Dermatitis—Losartan—type 2 diabetes mellitus	0.000615	0.00223	CcSEcCtD
Cyclopentolate—Pruritus—Ramipril—type 2 diabetes mellitus	0.000592	0.00215	CcSEcCtD
Cyclopentolate—Pethidine—CYP3A4—type 2 diabetes mellitus	0.000555	0.0829	CrCbGaD
Cyclopentolate—Rash—Ramipril—type 2 diabetes mellitus	0.000528	0.00191	CcSEcCtD
Cyclopentolate—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000527	0.00191	CcSEcCtD
Cyclopentolate—Pethidine—ALB—type 2 diabetes mellitus	0.000484	0.0723	CrCbGaD
Cyclopentolate—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	0.000483	0.0722	CrCbGaD
Cyclopentolate—Orphenadrine—CYP2E1—type 2 diabetes mellitus	0.000481	0.0718	CrCbGaD
Cyclopentolate—Orphenadrine—CYP3A4—type 2 diabetes mellitus	0.000303	0.0452	CrCbGaD
Cyclopentolate—CHRM3—Metabolism—HBA1—type 2 diabetes mellitus	7.32e-05	0.000353	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GCK—type 2 diabetes mellitus	7.32e-05	0.000353	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CYP11A1—type 2 diabetes mellitus	7.28e-05	0.000351	CbGpPWpGaD
Cyclopentolate—CHRM1—Circadian rythm related genes—IL6—type 2 diabetes mellitus	7.24e-05	0.000349	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	7.2e-05	0.000347	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	7.18e-05	0.000346	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—SLC9A1—type 2 diabetes mellitus	7.15e-05	0.000345	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	7.14e-05	0.000344	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	7.11e-05	0.000343	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	7.07e-05	0.000341	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	7.07e-05	0.000341	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CETP—type 2 diabetes mellitus	7.06e-05	0.000341	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SPRY2—type 2 diabetes mellitus	7.05e-05	0.00034	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	7.05e-05	0.00034	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	6.97e-05	0.000336	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—GNB3—type 2 diabetes mellitus	6.95e-05	0.000335	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—RBP4—type 2 diabetes mellitus	6.89e-05	0.000332	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	6.89e-05	0.000332	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—AVP—type 2 diabetes mellitus	6.88e-05	0.000332	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	6.88e-05	0.000332	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GLP1R—type 2 diabetes mellitus	6.87e-05	0.000331	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—RBP4—type 2 diabetes mellitus	6.87e-05	0.000331	CbGpPWpGaD
Cyclopentolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	6.86e-05	0.000331	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—AVP—type 2 diabetes mellitus	6.85e-05	0.00033	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—MMP3—type 2 diabetes mellitus	6.85e-05	0.00033	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	6.84e-05	0.00033	CbGpPWpGaD
Cyclopentolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	6.84e-05	0.00033	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	6.82e-05	0.000329	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	6.78e-05	0.000327	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCKAR—type 2 diabetes mellitus	6.76e-05	0.000326	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—SREBF1—type 2 diabetes mellitus	6.57e-05	0.000317	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—SNAP25—type 2 diabetes mellitus	6.57e-05	0.000317	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PSMD6—type 2 diabetes mellitus	6.57e-05	0.000317	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	6.54e-05	0.000315	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—EDN1—type 2 diabetes mellitus	6.52e-05	0.000314	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CTGF—type 2 diabetes mellitus	6.45e-05	0.000311	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	6.44e-05	0.00031	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	6.42e-05	0.000309	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—HMGCR—type 2 diabetes mellitus	6.39e-05	0.000308	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—GNB3—type 2 diabetes mellitus	6.38e-05	0.000308	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.38e-05	0.000308	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—HMOX1—type 2 diabetes mellitus	6.35e-05	0.000306	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—C3—type 2 diabetes mellitus	6.29e-05	0.000303	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—C3—type 2 diabetes mellitus	6.27e-05	0.000302	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CAT—type 2 diabetes mellitus	6.27e-05	0.000302	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ADRA2A—type 2 diabetes mellitus	6.25e-05	0.000301	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	6.21e-05	0.0003	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	6.19e-05	0.000299	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	6.14e-05	0.000296	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	6.12e-05	0.000295	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.1e-05	0.000294	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—APOB—type 2 diabetes mellitus	6.09e-05	0.000293	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.08e-05	0.000293	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—INSR—type 2 diabetes mellitus	6.07e-05	0.000293	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—INSR—type 2 diabetes mellitus	6.05e-05	0.000292	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CYP2E1—type 2 diabetes mellitus	6.01e-05	0.00029	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	5.98e-05	0.000288	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	5.96e-05	0.000287	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—AGT—type 2 diabetes mellitus	5.96e-05	0.000287	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	5.95e-05	0.000287	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TRPC6—type 2 diabetes mellitus	5.94e-05	0.000286	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—SLC2A1—type 2 diabetes mellitus	5.94e-05	0.000286	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CYP1A2—type 2 diabetes mellitus	5.94e-05	0.000286	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	5.93e-05	0.000286	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	5.93e-05	0.000286	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—GSTM1—type 2 diabetes mellitus	5.92e-05	0.000285	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AGTR2—type 2 diabetes mellitus	5.91e-05	0.000285	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	5.85e-05	0.000282	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CCR5—type 2 diabetes mellitus	5.83e-05	0.000281	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—LPL—type 2 diabetes mellitus	5.81e-05	0.00028	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CYP3A4—type 2 diabetes mellitus	5.79e-05	0.000279	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—C3—type 2 diabetes mellitus	5.71e-05	0.000275	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—C3—type 2 diabetes mellitus	5.69e-05	0.000275	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GCG—type 2 diabetes mellitus	5.69e-05	0.000275	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—SLC2A4—type 2 diabetes mellitus	5.69e-05	0.000275	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ADCY5—type 2 diabetes mellitus	5.69e-05	0.000274	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	5.67e-05	0.000274	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—GPX1—type 2 diabetes mellitus	5.67e-05	0.000273	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—EDNRB—type 2 diabetes mellitus	5.66e-05	0.000273	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	5.52e-05	0.000266	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CD36—type 2 diabetes mellitus	5.52e-05	0.000266	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.51e-05	0.000266	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.51e-05	0.000266	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	5.51e-05	0.000265	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.49e-05	0.000265	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.49e-05	0.000265	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PPP2CA—type 2 diabetes mellitus	5.45e-05	0.000263	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.43e-05	0.000262	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.41e-05	0.000261	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.36e-05	0.000258	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.34e-05	0.000258	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.34e-05	0.000257	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.34e-05	0.000257	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.32e-05	0.000257	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.32e-05	0.000256	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.24e-05	0.000253	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—MTHFR—type 2 diabetes mellitus	5.23e-05	0.000252	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.23e-05	0.000252	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.22e-05	0.000252	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.22e-05	0.000252	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.21e-05	0.000251	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.21e-05	0.000251	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.16e-05	0.000249	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.14e-05	0.000248	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PPARA—type 2 diabetes mellitus	5.13e-05	0.000248	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.02e-05	0.000242	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5e-05	0.000241	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—AGT—type 2 diabetes mellitus	4.97e-05	0.00024	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GNB3—type 2 diabetes mellitus	4.91e-05	0.000237	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.91e-05	0.000237	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CALM1—type 2 diabetes mellitus	4.89e-05	0.000236	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—HMOX1—type 2 diabetes mellitus	4.89e-05	0.000236	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—APOE—type 2 diabetes mellitus	4.87e-05	0.000235	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.86e-05	0.000234	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.84e-05	0.000234	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.84e-05	0.000233	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.82e-05	0.000232	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CAT—type 2 diabetes mellitus	4.82e-05	0.000232	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—APOA1—type 2 diabetes mellitus	4.81e-05	0.000232	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GCG—type 2 diabetes mellitus	4.78e-05	0.00023	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.78e-05	0.00023	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.76e-05	0.00023	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GCG—type 2 diabetes mellitus	4.76e-05	0.00023	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.7e-05	0.000227	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.68e-05	0.000226	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.68e-05	0.000226	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—APOB—type 2 diabetes mellitus	4.68e-05	0.000226	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.67e-05	0.000225	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GSTM1—type 2 diabetes mellitus	4.55e-05	0.00022	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.47e-05	0.000216	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—LPL—type 2 diabetes mellitus	4.47e-05	0.000215	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.46e-05	0.000215	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.39e-05	0.000212	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.39e-05	0.000212	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.38e-05	0.000211	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ADCY5—type 2 diabetes mellitus	4.37e-05	0.000211	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.37e-05	0.000211	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GPX1—type 2 diabetes mellitus	4.36e-05	0.00021	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CD36—type 2 diabetes mellitus	4.25e-05	0.000205	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PPARG—type 2 diabetes mellitus	4.24e-05	0.000205	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PPP2CA—type 2 diabetes mellitus	4.19e-05	0.000202	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—INS—type 2 diabetes mellitus	4.16e-05	0.000201	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.16e-05	0.0002	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.14e-05	0.0002	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.12e-05	0.000199	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.1e-05	0.000198	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	4.06e-05	0.000196	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.06e-05	0.000196	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.05e-05	0.000195	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AVP—type 2 diabetes mellitus	4.05e-05	0.000195	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.04e-05	0.000195	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.03e-05	0.000194	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.03e-05	0.000194	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	4.02e-05	0.000194	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.01e-05	0.000194	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.98e-05	0.000192	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.97e-05	0.000192	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	3.95e-05	0.00019	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	3.93e-05	0.000189	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	3.91e-05	0.000189	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.91e-05	0.000189	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.9e-05	0.000188	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.86e-05	0.000186	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.85e-05	0.000186	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	3.82e-05	0.000184	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ALB—type 2 diabetes mellitus	3.81e-05	0.000184	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	3.76e-05	0.000181	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	3.75e-05	0.000181	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	3.75e-05	0.000181	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	3.74e-05	0.00018	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	3.7e-05	0.000179	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.67e-05	0.000177	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.66e-05	0.000176	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PIK3R1—type 2 diabetes mellitus	3.65e-05	0.000176	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—NOS3—type 2 diabetes mellitus	3.65e-05	0.000176	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.52e-05	0.00017	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.51e-05	0.000169	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.45e-05	0.000167	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.44e-05	0.000166	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	3.37e-05	0.000163	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	3.36e-05	0.000162	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PTGS2—type 2 diabetes mellitus	3.34e-05	0.000161	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	3.26e-05	0.000157	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.22e-05	0.000155	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.21e-05	0.000155	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.21e-05	0.000155	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	3.21e-05	0.000155	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.2e-05	0.000154	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—INS—type 2 diabetes mellitus	3.2e-05	0.000154	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	3.2e-05	0.000154	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.15e-05	0.000152	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.14e-05	0.000152	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	3.14e-05	0.000152	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	3.14e-05	0.000152	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	3.13e-05	0.000151	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	3.13e-05	0.000151	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.11e-05	0.00015	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.1e-05	0.000149	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.96e-05	0.000143	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.95e-05	0.000142	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	2.93e-05	0.000141	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	2.81e-05	0.000135	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	2.81e-05	0.000135	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.8e-05	0.000135	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.79e-05	0.000135	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	2.68e-05	0.000129	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	2.68e-05	0.000129	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.64e-05	0.000127	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.63e-05	0.000127	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.6e-05	0.000125	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.59e-05	0.000125	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.59e-05	0.000125	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.59e-05	0.000125	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.58e-05	0.000125	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.57e-05	0.000124	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	2.57e-05	0.000124	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.47e-05	0.000119	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.46e-05	0.000119	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.35e-05	0.000114	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.35e-05	0.000114	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.35e-05	0.000113	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.35e-05	0.000113	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.22e-05	0.000107	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	2.21e-05	0.000106	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.02e-05	9.73e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.01e-05	9.7e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2e-05	9.64e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.99e-05	9.61e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.99e-05	9.57e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.98e-05	9.54e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.89e-05	9.11e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.88e-05	9.08e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.87e-05	9.01e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.86e-05	8.98e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.83e-05	8.83e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.83e-05	8.8e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.74e-05	8.4e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.74e-05	8.37e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.7e-05	8.18e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.69e-05	8.15e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—AKT1—type 2 diabetes mellitus	1.68e-05	8.09e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.56e-05	7.51e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.55e-05	7.48e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.53e-05	7.36e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.52e-05	7.34e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	1.29e-05	6.22e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.17e-05	5.66e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.17e-05	5.64e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.08e-05	5.22e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.08e-05	5.2e-05	CbGpPWpGaD
